Policy specialists taking part in a recent PBGH roundtable on drug costs noted the reforms continue to enjoy broad, bi-partisan support and will help address a top concern of the American people in an election year.
Large employers are increasingly working with existing direct contracting partners and new vendors to enhance primary care, which includes, among other things, the integration of behavioral health care.
With the country in its fifth wave of coronavirus cases and hospitals full to the point of breaking, the ongoing pandemic clouds and shapes the health policy landscape.
At the recent PBGH year-end roundtable, noted health care futurist Ian Morrison discussed key health care trends that both he and PBGH believe will be most relevant to purchasers in the year ahead.
The PBGH Innovate blog features articles written by PBGH and other experts about drug prices and fights over legislation to reign them in, health care market consolidation, payment reform, surprise medical bills, hospital price transparency, advanced primary care and beyond.
Large employers and health care purchasers have increasingly begun to take actionable steps to strengthen primary care, the critical precursor to a high-quality, cost-effective health care system.
A landmark federal rule requires the nation’s 6,000 hospitals to make pricing data available publicly. This requirement includes plan-specific negotiated prices, not just the “chargemaster” prices, for every item or service.
If the reconciliation bill currently being debated in Congress includes Medicare-only drug price limits, the 180 million Americans with private health coverage would be left behind.
Here’s the problem with the drug industry’s top talking point: It’s a lie.
Through successive initiatives and in collaboration with a diverse group of committed stakeholders, PBGH has spearheaded efforts to create a blueprint for “advanced primary care.”